Navigation Links
ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
Date:11/9/2009

GLEN ROCK, Pa., Nov. 9 /PRNewswire/ -- ARmark Authentication Technologies, LLC, and Colorcon, Inc. announced today an alliance in the development and introduction of ®mark® On-Dose ID(TM), an authentication technology that incorporates microscopic covert micro-tags into the immediate-release film coatings of solid oral dosage forms (SODFs) to prevent counterfeiting. The alliance provides Colorcon exclusive rights to market ARmark's micro-tags for tablet film coatings and to market this technology to pharmaceutical manufacturers globally.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091109/PH06061 )

By leveraging the tablet coating expertise of Colorcon, a world leader in the manufacture and development of specialized film coatings, and ARmark's customized micro-tag authentication technology, the two companies collaborated to develop ®mark® On-Dose ID. The micro-tags are seamlessly integrated into existing tablet film coating processes without additional manufacturing steps or capital investments. By incorporating the micro-tags directly into a tablet's film coating, drug manufacturers achieve reliable placement on each and every tablet.

The customized micro-tags can hold significant amounts of brand-owner specific, encrypted information such as lot and batch ID numbers, logos and other text, patterns, shapes and symbols, in a particle the size of 75-110 microns, a space smaller than the diameter of a human hair. Nearly impossible to replicate or reverse engineer, the markers are compatible with other covert or overt identification technologies and can also be incorporated as part of labels, bottles, paper and blister packaging.

"The availability of this authentication technology is significant to drug manufacturers because adding ®mark® micro-tags to an existing immediate release film coated tablet can now be considered to be a SUPAC Level 1 annual reportable change," states Jeff Robertson, Director and General Manager at ARmark Authentication Technologies, LLC. "That means drug manufacturers can quickly begin using the On-Dose ID technology to protect their product without prior approval from the FDA."

®mark® covert marker technology has been available for more than two years in other markets, but the recent draft guidance issued by the Food and Drug Administration (FDA) regarding the use of physical chemical identifiers (PCIDs) defines how the commercial utilization of micro-tag technology can be used for on-dose authentication in the pharmaceutical industry. In accordance to the FDA's guidance document, ARmark manufactures the micro-tags from approved excipient materials generally regarded as safe (GRAS) or from the FDA's Inactive Ingredient Guide (IIG), under cGMP conditions.

According to Dr. Kamlesh Oza, Colorcon's General Manager of Film Coatings, "Colorcon's studies have shown there is no impact on dissolution or stability when the ®mark® On-Dose ID micro-tags are incorporated into an existing film-coated dosage form. This approach is in compliance to the FDA's guidance, enabling pharmaceutical companies to provide patients with safe security augmentation. As companies adopt this anticounterfeiting technology to quickly secure their brands, our studies will help them note the addition of micro-tags in their annual reports as required by the FDA."

The ®mark® On-Dose ID micro-tags are invisible to the naked eye once they are incorporated into a tablet film coating, but are easily identified with ®vision® optical viewing systems. These portable tools authenticate products by magnifying the micro-tags at any stage following the tablet coating process. The ®vision® system enables accurate, in-field detection within a matter of seconds without destroying the SODF sample.

Colorcon, Inc. is a world leader in the development, supply and technical support of fully formulated products for the pharmaceutical and dietary supplement industry. Its core businesses include film coatings, modified release technologies, functional excipients, and tablet branding services. Colorcon has 18 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base. For more information on Colorcon capabilities and its products, call 215-699-7733 or visit www.colorcon.com.

ARmark Authentication Technologies, LLC, based in Glen Rock, PA, develops custom authentication systems for brand protection, product surety and risk mitigation to fight global counterfeiting. Our technologies protect our clients' products with brand-owner-specific information so that the authenticity of these products becomes Indisputable. ARmark Authentication Technologies, LLC services a variety of industries, including but not limited to: pharmaceutical, medical devices, luxury goods, electronics, secure documents, food and apparel. ARmark Authentication Technologies, LLC is a wholly-owned subsidiary of Adhesives Research, Inc. For more information on ARmark Authentication Technologies, LLC and its products, call 1-717-227-5920 or visit www.rmark.org.

®mark® is a registered trademark and On-Dose ID(TM) is a trademark of ARmark Authentication Technologies, LLC. ARmark® is a registered trademark of Adhesives Research, Inc.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Jeff Robertson

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=90114

SOURCE ARmark Authentication Technologies, LLC


'/>"/>
SOURCE ARmark Authentication Technologies, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Event for People With Disabilities on November 6-8 Features Latest Technologies, Products, Services, and More
2. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
3. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
4. Blue Belt Technologies, Inc. Closes Series A Financing
5. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
6. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
7. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
8. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
9. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
10. Wound Management Technologies, Inc. Announces Evidence Based Study
11. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... Nov 30, 2016 Research and Markets has ... Monitoring Devices 2017 - MedCore" report to their offering. ... , , ... the skull. In healthy individuals, it is circulated though the brain and ... where the amount of CSF surrounding the brain changes significantly. ...
(Date:11/30/2016)... Research and Markets has announced the addition of the ... their offering. ... Detachable coil embolization is a minimally invasive method ... embolization treatment of cerebral aneurysms is less invasive and requires less recovery ... wall of an artery in the brain. This area bulges in the ...
(Date:11/30/2016)... Calif. , Nov. 30, 2016 Varian ... it was named America,s Most JUST Company in the ... and Forbes magazine,s inaugural "JUST 100 List." ... of the largest surveys ever conducted on attitudes towards ... months. This inaugural list ranks U.S companies against their ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... proudly announces the launch of its 60-day free trial program for all of ... shipping make the offer a truly hassle free experience. , FlexiSpot’s unique desktop ...
(Date:12/2/2016)... ... 02, 2016 , ... With the number of pain management programs available for ... find the one that works for them. When an inventor from Suisun City, Calif., ... and decided to share it with others. , He developed a prototype for PRO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to ... which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping ... prolonging life 6 years in the last 3 decades,” says Dr. Valentine Fuster, ...
(Date:12/2/2016)... ... , ... Sourced from the Isbre Springs beneath the 5,000 year old Hardanger ... of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent taste ... several ShopRite and FoodTown stores in NJ and received rave comments from consumers. , ...
(Date:12/2/2016)... Francisco, CA (PRWEB) , ... December 02, 2016 ... ... digitally-enabled care journeys, announced today that it has raised $6.0 million in an ... inspired by Clarify Health’s conviction that patients and their caregivers can receive far ...
Breaking Medicine News(10 mins):